FARN Faron Pharmaceuticals Oy

0.3621USD27.50 GBp · LSE-1.79%Mkt Cap: 73.47M USDP/E: —

Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidate is Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of…